Onemednet Corp（ONMD）资讯与事件ONMDOnemednet Corp

OneMedNet Receives Mid Six-Figure Reorder to Support AI Radiology Model Development

OneMedNet announced that it has received a mid six-figure re-order from a previously announced foundation model company developing advanced AI models for radiology. This order follows OneMedNet's delivery of the first dataset under the customer agreement - based on the quality and completeness of that data. The customer is expanding on the multi-modal imaging data agreement, which was included as part of the more than $3M in new bookings the company announced on June 10, including engagements supporting foundation model development. Under the agreement, OneMedNet delivers de-identified, multi-modal studies at scale, sourced directly from its healthcare provider partners. The re-order increases that data volume as the customer advances its model development. AI development in foundation radiology modeling depends on full-fidelity DICOM studies and images - complete imaging series with intact pixel data and acquisition metadata - delivered at scale. OneMedNet de-identifies each study at the source while preserving the diagnostic fidelity these models require, a standard that is difficult to meet with compressed or stripped-down secondary data.

OneMedNet Secures High Six-Figure Add-On Order, Data Volume Up 150%

OneMedNet announced that it has received a high six-figure add-on order under the multiyear agreement announced on September 30. The order exercises the expansion option included in that agreement, increasing data volume by 150% with the commercially scaled AI-enabled precision medicine customer. The September 30 agreement established a multiyear license for de-identified, multimodal, longitudinal clinical Real-World Data. The customer is using the data to train AI-enabled clinical and diagnostic models and to build a licensable derivative dataset for sale into its own channel.

OneMedNet Partners with Pharma Intelligence Provider

OneMedNet announced a channel partner agreement with a provider of pharmaceutical intelligence and data solutions will distribute OneMedNet's U.S.-sourced, de-identified clinical data to its established base of pharmaceutical customers worldwide.